ClinicalTrials.Veeva

Menu

Simplified Severe Sepsis Protocol in Zambia (SSSP)

Vanderbilt University logo

Vanderbilt University

Status

Terminated

Conditions

Severe Sepsis
Sepsis

Treatments

Other: Simplified Severe Sepsis Protocol

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT01449916
R24TW007988 (U.S. NIH Grant/Contract)
SSSP

Details and patient eligibility

About

This study is a randomized control trial assessing the impact of a simple evidence-based protocol for the treatment severe sepsis in Zambia. The intervention protocol consists of a scheduled fluid regimen, early blood culture and antibiotics, and dopamine and blood transfusion when necessary. It is hypothesized that the protocol will significantly decrease in-hospital mortality in patients with severe sepsis.

Full description

In recent years, evidence-based protocols of bundled therapies have improved survival of severe sepsis in developed countries. However, in sub-Saharan Africa, simple therapies such as IV fluids and early antibiotics are frequently under-utilized. Furthermore, although tuberculosis is a common cause of severe sepsis in the region, accurate and timely diagnosis of tuberculosis-associated severe sepsis remains elusive.

The aims of this study are (1) To assess the impact on survival of a simple evidence-based protocol for severe sepsis, (2) To evaluate the cost of implementation for a simplified severe sepsis protocol (3) To develop a clinical diagnostic score for identifying tuberculosis in HIV positive patients with severe sepsis (4) To assess the performance of the Xpert TB/RIF rapid PCR system for diagnosing tuberculosis in HIV positive patients with severe sepsis.

Enrollment

112 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 or older

  • Suspected infection

  • 2 or more of SIRS criteria:

    • Heart rate >90/min
    • Respiratory rate >20/min
    • Temperature >= 38° C or <= 36° C
    • White blood count > 12,000 or < 4,000/µL
  • 1 or more of the following signs of end-organ dysfunction

    • Systolic blood pressure < 90 mm Hg
    • Mean arterial blood pressure (MAP) < 65 mm Hg
    • Confusion/altered mentation
    • Urine output < 0.5 mL/kg/hr
    • Creatinine increase > 0.5 mg/dL
    • Creatinine > 0.5 mg/dL above upper limit of normal
    • Platelet < 100x109/L
    • Respiratory rate > 40/min
    • Jaundice

Exclusion criteria

  • GI bleed
  • Need for urgent surgery

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

112 participants in 2 patient groups

Simplified Severe Sepsis Protocol
Experimental group
Description:
This protocol consists of an early aggressive fluid strategy, early blood cultures and antibiotics, and, when appropriate, blood transfusion and titratable dopamine. Monitoring is based on physical exam findings.
Treatment:
Other: Simplified Severe Sepsis Protocol
Usual care
Active Comparator group
Description:
Early blood cultures and antibiotics. Monitoring by study nurses as in experimental arm. Other interventions are according to admitting (non-study) doctors' orders.
Treatment:
Other: Simplified Severe Sepsis Protocol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems